Saturday, August 22, 2026
Claude autonomously designs protein binders in lab tests
Anthropic said Claude's Mythos Preview and Opus 4.8 models autonomously ran an end-to-end computational design pipeline that produced working protein binders against 14 of 15 targets, yielding 354 confirmed binders from 1,320 designs validated in the lab by partners Adaptyv Bio and Twist Bioscience. Hit rates reached 26.7% and 22.6% for the two models, well above the 10-15% typical for human-led protein-design campaigns, though Anthropic cautioned the binders are a first step and not drugs.
/ Sources
/ About this story
Compiled by Venture Atlas from the sources above, using automated AI-assisted research. This is a summary of reporting published elsewhere, not original reporting - follow the source links for the full account. See our editorial standards.
Something wrong here? Email flightatlas.contact@gmail.com and we will fix it.
/ Related
- OpenAI Q2 revenue hits $6.7B as Anthropic overtakes it in salesThursday, August 20, 2026
- Anthropic preps super-voting shares, credit facility past $10BWednesday, August 19, 2026
- Anthropic's revenue run rate tops $65 billion ahead of IPOWednesday, August 19, 2026
- Anthropic hit by 36-minute authentication outage across ClaudeMonday, August 17, 2026